RJA
VIR icon

Raymond James & Associates’s Vir Biotechnology VIR Stock Holding History

Raymond James & Associates’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-74,113
Closed -$660K – 4111
2024
Q2 		$660K Buy
+74,113
New +$711K ﹤0.01% 2890
2021
Q2 		– Sell
-3,975
Closed -$204K – 4221
2021
Q1 		$204K Sell
3,975
-13,575
-77% -$732K ﹤0.01% 3600
2020
Q4 		$470K Buy
17,550
+4,150
+31% +$135K ﹤0.01% 2852
2020
Q3 		$460K Buy
13,400
+206
+2% +$8.87K ﹤0.01% 2692
2020
Q2 		$541K Buy
+13,194
New +$443K ﹤0.01% 2529

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return